Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
  1. Home
  2. Search

Refine search

Refine search

Access:
Content type:
Publication date:
Apply   From and To filters
Subject: Show more
Journals Show more
Publishers: Show more
Societies Show more
Series: Show more
Collections: Show more

Actions for selected content:

Select all | Deselect all
  • View selected items
  • Export citations
  • Download PDF (zip)
  • Save to Kindle
  • Save to Dropbox
  • Save to Google Drive

Save Search

You can save your searches here and later view and run them again in "My saved searches".

Please provide a title, maximum of 40 characters.
Cancel
×

1 results

  • 30 - Fertility treatment: science and reality – the NHS and the market

  • from SECTION 8 - FERTILITY TREATMENT: SCIENCE AND REALITY – THE NHS AND THE MARKET
  • Edited by Susan Bewley, William Ledger, University of New South Wales, Sydney, Dimitrios Nikolaou
  • Book:
    Reproductive Ageing
    Published online:
    05 February 2014
    Print publication:
    01 June 2009, pp 313-318

  • Summary

    This chapter presents a discussion between Diana Mansour, Berkeley Greenwood, David Barlow, Siladitya Bhattycharya, Berkeley Greenwood, and Susan Bewley. Each participant presents his/her points pertaining to science and reality, and NHS and market with regard to fertility treatment. Bewley questions if the relief of infertility and the costs of pain and stress could be measured in quality-adjusted life years (QALYs), do taxpayers not wish to help two couples for their pound, rather than one. There is more infertility, thanks to treatment existing, than in the days when treatments did not exist. Primary prevention of infertility is also critical. The cost of a live birth becomes twice as expensive beyond the age of 39, hence the existing NICE guideline recommends funding up to the age of 39. In Greenwood's view, 40 is a reasonable cut-off. IVF will see a reduction in monies if there is funding for more NHS treatments.